Asthma
RecruitingStudy on Tezepelumab for Children Aged 5 to 11 with Severe Asthma
Study on Tezepelumab for Children Aged 5 to 11 with Severe Asthma
- Disease:Asthma
- Substances:Tezepelumab
France- Participants:0–17 years
- Substances:Tezepelumab
Rare diseases
Investigational molecules
Locations
Study on Tezepelumab for Children Aged 5 to 11 with Severe Asthma
FranceEfficacy and Safety of Givinostat for Non-Ambulant Patients with Duchenne Muscular Dystrophy
BelgiumStudy of Fluoroestradiol F-18 and Biomarkers for Women with ER-Positive HER2-Negative Metastatic Breast Cancer After CDK4/6 Inhibitor Therapy
FranceStudy on the Effectiveness and Safety of Dapirolizumab Pegol for Patients with Moderate to Severe Systemic Lupus Erythematosus
BelgiumStudy on the Effects of Dobutamine on Heart Function in Patients with Wild-type Transthyretin Amyloid Cardiomyopathy
DenmarkStudy on Using ctDNA to Guide Treatment in Patients with Metastatic Colorectal Cancer Using Oxaliplatin, Capecitabine, Calcium Folinate, Irinotecan, and Fluorouracil
DenmarkStudy on Early Detection of Triple-Negative Breast Cancer Relapse Using 68Ga-FAPI-46 for Patients at High Risk
FranceStudy on Ceftriaxone Dosing for Patients with Severe Community-Acquired Pneumonia
BelgiumStudy on Shortened Treatment with Apalutamide and Enzalutamide for Patients with Low-Volume Metastatic Castration-Sensitive Prostate Cancer
The NetherlandsStudy on Olaparib for Patients with p53abn Endometrial Cancer After Chemoradiation Therapy
FranceStudy on the Long-Term Safety of Dapirolizumab Pegol for Patients with Systemic Lupus Erythematosus
BelgiumStudy on Ciclosporin for Treating Atopic Keratoconjunctivitis in Adults
DenmarkTell us about your condition – we search every trial in Europe and connect you with the right site.